NEW YORK (GenomeWeb News) — Invitrogen said today that its Invitrogen Federal Systems subsidiary has been awarded a $1.2 million extension to its contract with the US Department of Defense.
 
According to Invitrogen, the contract will support research using its ProtoArray protein microarray platform to detect and analyze biothreat agents such as hemorrhagic fever viruses, poxviruses, and anthrax.  
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.